In this paper A/Prof Alex Polyakov and Dr Genia Rozen highlight how new reproductive medicine technologies often spark initial excitement but can lead to disappointment when prematurely adopted without thorough testing. It argues that overconfidence in unproven methods, fueled by the Dunning-Kruger effect, exacerbates this cycle and risks patient safety. Using the example of the endometrial scratch, the authors advocate for stricter vetting of innovations through comprehensive data collection and oversight. Establishing national and international databases would allow continuous monitoring of new treatments, ensuring that only evidence-based advancements that benefit patients are widely adopted.
